Chester step test: assessment of functional capacity and magnitude of cardiorespiratory response in patients with COPD and healthy subjects

Fuente: Redalyc
Guardado en:
Detalles Bibliográficos
Autor principal: Manuela Karloh
Formato: Artículo científico
Lenguaje:en
Publicado: Associação Brasileira de Pesquisa e Pós-Graduação em Fisioterapia 2013
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1876455528258863104
author Manuela Karloh
author_facet Manuela Karloh
contents Chester step test: assessment of functional capacity and magnitude of cardiorespiratory response in patients with COPD and healthy subjects Manuela Karloh Krislainy S. Corrêa Letícia Q. Martins Cintia L. P. Araujo Darlan L. Matte Anamaria F. Mayer Salud evaluation Rehabilitation exercise tolerance functional capacity chronic obstructive pulmonary disease Background: the assessment of functional capacity in patients with chronic obstructive pulmonary disease (COPD) has been performed by simple and easy to apply methods that mimic everyday activities, such as the Chester step test (TChester). Objectives: to investigate whether TChester is able to differentiate functional capacity and the magnitude of cardiorespiratory response of patients with COPD from healthy subjects; and to compare it with the cardiorespiratory response induced by shuttle test (TShuttle) and six-minute walk test (6MWT). Method: 10 patients with COPD (64±10 years, and forced expiratory volume at the first second - FEV1 38.1±11.8% predicted) and 10 healthy subjects (63±7 years, and FEV1 of 95.8±18.0% predicted) underwent evaluation of pulmonary function, functional status and capacity (6MWT, TShuttle and TChester). Results: COPD patients had worst performance in all tests, when compared to healthy subjects (TChester 2,1±0,9 vs. 4,1±1,1 completed levels; TC6min: 435±105,1 vs. 593±87,3 m; TShuttle 251±84,6 vs. 436±55,4 m; p<0.05). TChester correlated with TShuttle and 6MWT (r =0.67 and 0.83, respectively, p<0.05). There were no differences in heart rate and dyspnea in TChester levels between groups (p>0.05). SpO2 was lower in COPD patients since the first TChester level (p<0.05). Conclusion: TChester is valid in the assessment of functional capacity of COPD patients, being able to distinguish them from healthy subjects, inducing similar cardiovascular demand and greater desaturation in COPD patients. 2013 artículo científico 1413-3555 https://www.redalyc.org/articulo.oa?id=235027942003 en http://www.redalyc.org/revista.oa?id=2350 Revista Brasileira de Fisioterapia application/pdf Associação Brasileira de Pesquisa e Pós-Graduação em Fisioterapia Revista Brasileira de Fisioterapia (Brasil) Num.3 Vol.17
format Artículo científico
id redalyc_235027942003
institution Redalyc
language en
publishDate 2013
publisher Associação Brasileira de Pesquisa e Pós-Graduação em Fisioterapia
spellingShingle Chester step test: assessment of functional capacity and magnitude of cardiorespiratory response in patients with COPD and healthy subjects
Manuela Karloh
Salud
evaluation
Rehabilitation
exercise tolerance
functional capacity
chronic obstructive pulmonary disease
Chester step test: assessment of functional capacity and magnitude of cardiorespiratory response in patients with COPD and healthy subjects Manuela Karloh Krislainy S. Corrêa Letícia Q. Martins Cintia L. P. Araujo Darlan L. Matte Anamaria F. Mayer Salud evaluation Rehabilitation exercise tolerance functional capacity chronic obstructive pulmonary disease Background: the assessment of functional capacity in patients with chronic obstructive pulmonary disease (COPD) has been performed by simple and easy to apply methods that mimic everyday activities, such as the Chester step test (TChester). Objectives: to investigate whether TChester is able to differentiate functional capacity and the magnitude of cardiorespiratory response of patients with COPD from healthy subjects; and to compare it with the cardiorespiratory response induced by shuttle test (TShuttle) and six-minute walk test (6MWT). Method: 10 patients with COPD (64±10 years, and forced expiratory volume at the first second - FEV1 38.1±11.8% predicted) and 10 healthy subjects (63±7 years, and FEV1 of 95.8±18.0% predicted) underwent evaluation of pulmonary function, functional status and capacity (6MWT, TShuttle and TChester). Results: COPD patients had worst performance in all tests, when compared to healthy subjects (TChester 2,1±0,9 vs. 4,1±1,1 completed levels; TC6min: 435±105,1 vs. 593±87,3 m; TShuttle 251±84,6 vs. 436±55,4 m; p<0.05). TChester correlated with TShuttle and 6MWT (r =0.67 and 0.83, respectively, p<0.05). There were no differences in heart rate and dyspnea in TChester levels between groups (p>0.05). SpO2 was lower in COPD patients since the first TChester level (p<0.05). Conclusion: TChester is valid in the assessment of functional capacity of COPD patients, being able to distinguish them from healthy subjects, inducing similar cardiovascular demand and greater desaturation in COPD patients. 2013 artículo científico 1413-3555 https://www.redalyc.org/articulo.oa?id=235027942003 en http://www.redalyc.org/revista.oa?id=2350 Revista Brasileira de Fisioterapia application/pdf Associação Brasileira de Pesquisa e Pós-Graduação em Fisioterapia Revista Brasileira de Fisioterapia (Brasil) Num.3 Vol.17
title Chester step test: assessment of functional capacity and magnitude of cardiorespiratory response in patients with COPD and healthy subjects
topic Salud
evaluation
Rehabilitation
exercise tolerance
functional capacity
chronic obstructive pulmonary disease
url https://www.redalyc.org/articulo.oa?id=235027942003